Smartphone Sound Test for Lung and Airway Conditions
Tests whether smartphone sounds can assess airways in people with lung disease.
Plain-language title generated from the registry record
Registry title: Acoustic Waveform Respiratory Evaluation
Key facts
- Where
- Indianapolis and Pittsburgh, United StatesSee the 2 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 8 and 70 years old?
Source: NCT06512064, who can take part
Where in United States
- Indiana UniversityIndianapolis, United StatesTaking people
- University of PittsburghPittsburgh, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Indiana University
- Trial code
- NCT06512064
- Record updated
- 5 October 2026
- Original description
The study will evaluate the feasibility of using smartphone speakers and microphones to evaluate the caliber of the airways, detect airway obstruction, aid in airway disease diagnosis, and identify disease exacerbations.Read full original descriptionShow less
Advancing Telemedicine in Pulmonology: Acoustic-waveform Respiratory Evaluation (AWARE) Via Sensing and Machine Learning on Smartphones
The study will evaluate the feasibility of using smartphone speakers and microphones to evaluate the caliber of the airways, detect airway obstruction, aid in airway disease diagnosis, and identify disease exacerbations.
Inclusion: Age 8-70 years (to ensure ability to perform other PFTs; up to 75 years for COPD subjects in the UPMC adult clinic only); Ability to perform spirometry and oscillometry; Signed informed consent (and assent for children as appropriate); No respiratory or other major disease (for healthy controls), or physician-diagnosed asthma, COPD, CF, or other airway diseases.
Exclusion: Acute or chronic illness that, at the judgement of investigators, may affect lung function and alter the results of AWARE or the reference PFTs (spirometry and AOS); Inability or unwillingness to perform AWARE, spirometry, or oscillometry.